Gene · 4172
Papers2,183
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,183
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Matrine Targets BTF3 to Inhibit the Growth of Canine Mammary Tumor Cells. | Int J Mol Sci | 2023 | 38203709 | PubTator, text mining | PubMed |
| CYP1B1 promotes colorectal cancer liver metastasis by enhancing the growth of metastatic cancer cells via a fatty acids-dependent manner. | J Gastrointest Oncol | 2023 | 38196537 | PubTator, text mining | PubMed |
| Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma. | Cancer Res | 2023 | 38098449 | PubTator, text mining | PubMed |
| Identification of druggable hub genes and key pathways associated with cervical cancer by protein-protein interaction analysis: An in silico study. | Int J Reprod Biomed | 2023 | 38077941 | PubTator, text mining | PubMed |
| A differential diagnosis between uterine leiomyoma and leiomyosarcoma using transcriptome analysis. | BMC Cancer | 2023 | 38066476 | PubTator, text mining | PubMed |
| Single-cell Analysis Reveals Inter- and Intratumour Heterogeneity in Metastatic Breast Cancer. | J Mammary Gland Biol Neoplasia | 2023 | 38066300 | PubTator, text mining | PubMed |
| An integrative evaluation of circadian gene TIMELESS as a pan-cancer immunological and predictive biomarker. | Eur J Med Res | 2023 | 38053143 | PubTator, text mining | PubMed |
| SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma. | Nat Commun | 2023 | 38030644 | PubTator, text mining | PubMed |
| Epigenetic switch reshapes epithelial progenitor cell signatures and drives inflammatory pathogenesis in hidradenitis suppurativa. | Proc Natl Acad Sci U S A | 2023 | 38011564 | PubTator, text mining | PubMed |
| Ellagic Acid and Cancer Hallmarks: Insights from Experimental Evidence. | Biomolecules | 2023 | 38002335 | PubTator, text mining | PubMed |
| Modulation of SLFN11 induces changes in DNA Damage response in breast cancer. | Cancer Cell Int | 2023 | 38001424 | PubTator, text mining | PubMed |
| Integrated small RNA, mRNA and protein omics reveal a miRNA network orchestrating metabolic maturation of the developing human heart. | BMC Genomics | 2023 | 37996818 | PubTator, text mining | PubMed |
| Loss of p53-DREAM-mediated repression of cell cycle genes as a driver of lymph node metastasis in head and neck cancer. | Genome Med | 2023 | 37978395 | PubTator, text mining | PubMed |
| AGEs and RAGE: metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancers. | Explor Target Antitumor Ther | 2023 | 37970208 | PubTator, text mining | PubMed |
| Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development. | World J Gastrointest Oncol | 2023 | 37969406 | PubTator, text mining | PubMed |
| The nucleolar protein GNL3 prevents resection of stalled replication forks. | EMBO Rep | 2023 | 37965896 | PubTator, text mining | PubMed |
| Selective activator of human ClpP triggers cell cycle arrest to inhibit lung squamous cell carcinoma. | Nat Commun | 2023 | 37923710 | PubTator, text mining | PubMed |
| Sirtuin 2 promotes human cytomegalovirus replication by regulating cell cycle progression. | mSystems | 2023 | 37916830 | PubTator, text mining | PubMed |
| MmuPV1 E6 induces cell proliferation and other hallmarks of cancer. | mBio | 2023 | 37905801 | PubTator, text mining | PubMed |
| Insights into common fragile site instability: DNA replication challenges at DNA repeat sequences. | Emerg Top Life Sci | 2023 | 37876349 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4172/papers?page=5